share_log

Anebulo Pharmaceuticals Q1 EPS $(0.11) Down From $(0.07) YoY

Benzinga Real-time News ·  Nov 10, 2022 08:07

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.11) per share. This is a 57.14 percent decrease over losses of $(0.07) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment